M Diagnosis NIRS and Treatment BVS of Vulnerable Plaque: PROSPECT II - Gregg Stone, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Atherosclerosis & Research - Vulnerable Plaque Clinical Trials Update

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

M Diagnosis NIRS and Treatment BVS of Vulnerable Plaque: PROSPECT II presented by Gregg Stone, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$6.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physiology technicians
  • Nurses and other allied healthcare professionals 
  • Imaging Specialists
  • Radiologists

Session Name: Vulnerable Plaque Clinical Trials Update

Track: Atherosclerosis & Research

Learning Objectives

  • The latest updates in Atherosclerosis & Research

Other Components in this Moment

Overview
Near-infrared Spectroscopy: Lipid-rich Plaque Study Update - Ron Waksman, MD, FSCAI
M Diagnosis NIRS and Treatment BVS of Vulnerable Plaque: PROSPECT II - Gregg Stone, MD, FSCAI
Genomics and CV Risk - Michael Davidson, MD
Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome - Amir Lerman, MD
Loading Simple Education